Quick Answer
ENDONOVO THERAPEUTICS, INC. reported Total Assets of $1.28 million for fiscal year 2022.
ENDONOVO THERAPEUTICS, INC. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2022 | $1.28M | -36.2% |
| 2021 | $2.01M | -23.0% |
| 2020 | $2.61M | -20.4% |
| 2019 | $3.27M | -22.8% |
| 2018 | $4.24M | -8.0% |
| 2017 | $4.61M | +1347.3% |
| 2016 | $318.7K | -22.2% |
| 2015 | $409.4K | +797.9% |
| 2014 | $45.6K | -37.8% |
| 2011 | $73.3K | -56.4% |
| 2010 | $167.9K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2023 | $815.8K | -43.8% | -19.6% |
| June 30, 2023 | $1.01M | -36.4% | -15.4% |
| March 31, 2023 | $1.20M | -33.9% | -6.4% |
| December 31, 2022 | $1.28M | -36.2% | -11.7% |
| September 30, 2022 | $1.45M | -32.1% | -9.0% |
| June 30, 2022 | $1.59M | -29.9% | -12.1% |
| March 31, 2022 | $1.82M | -28.0% | -9.6% |
| December 31, 2021 | $2.01M | -23.0% | -6.1% |
- ENDONOVO THERAPEUTICS, INC. showed a decrease of -36.2% in Total Assets compared to the prior fiscal year.
- Over the 2010–2022 period, ENDONOVO THERAPEUTICS, INC.’s total assets has grown by 662.9% (from $167.9 thousand to $1.28 million).
- The most recent figure is from ENDONOVO THERAPEUTICS, INC.’s fiscal year 2022 report (Form 10-K), filed with the SEC on April 17, 2023.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: